Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Perla

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Leukemia|February 3, 1998
Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancerL M Melillo, M R Sajeva, P Musto, et al.
Haematologica|November 1, 1994
Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytesP Musto, S Modoni, G Alicino, et al.
Leukemia & Lymphoma|June 28, 2001
Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center studyA M Carella, N Cascavilla, M M Greco, et al.
British Journal of Haematology|May 1, 1995
Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemiaP Musto, C Bodenizza, A Falcone, et al.
European Journal of Gynaecological Oncology|July 28, 1999
Establishment and growth regulation of a novel ovarian cancer cell line from a poorly-differentiated adenocarcinoma: proposal for a new treatmentA Mancini, A Borrelli, S Formisano, et al.
Leukemia & Lymphoma|March 18, 2000
Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 casesN Cascavilla, L Melillo, G D'Arena, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Leukemia|February 3, 1998
Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancerL M Melillo, M R Sajeva, P Musto, et al.
Haematologica|November 1, 1994
Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytesP Musto, S Modoni, G Alicino, et al.
Leukemia & Lymphoma|June 28, 2001
Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center studyA M Carella, N Cascavilla, M M Greco, et al.
British Journal of Haematology|May 1, 1995
Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemiaP Musto, C Bodenizza, A Falcone, et al.
European Journal of Gynaecological Oncology|July 28, 1999
Establishment and growth regulation of a novel ovarian cancer cell line from a poorly-differentiated adenocarcinoma: proposal for a new treatmentA Mancini, A Borrelli, S Formisano, et al.
Leukemia & Lymphoma|March 18, 2000
Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 casesN Cascavilla, L Melillo, G D'Arena, et al.
Pageof 3